Samuel J. Klempner

11.7k total citations · 3 hit papers
197 papers, 5.4k citations indexed

About

Samuel J. Klempner is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Samuel J. Klempner has authored 197 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Oncology, 116 papers in Pulmonary and Respiratory Medicine and 46 papers in Cancer Research. Recurrent topics in Samuel J. Klempner's work include Gastric Cancer Management and Outcomes (63 papers), Lung Cancer Treatments and Mutations (46 papers) and Cancer Genomics and Diagnostics (42 papers). Samuel J. Klempner is often cited by papers focused on Gastric Cancer Management and Outcomes (63 papers), Lung Cancer Treatments and Mutations (46 papers) and Cancer Genomics and Diagnostics (42 papers). Samuel J. Klempner collaborates with scholars based in United States, South Korea and Japan. Samuel J. Klempner's co-authors include Siraj M. Ali, Sai‐Hong Ignatius Ou, Alexa B. Schrock, Jeffrey S. Ross, Vincent A. Miller, Joseph Chao, Alexander G. Raufi, Ethan S. Sokol, Marwan Fakih and David Fabrizio and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Samuel J. Klempner

187 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer

2019 441 citations Alexa B. Schrock, Ethan S. Sokol et al. profile →
Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation

2021 302 citations Noritaka Tanaka, W. Marston Linehan et al. Cancer Discovery profile →
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C

2022 269 citations Tanios Bekaii‐Saab, Samuel J. Klempner et al. profile →

Peers

Countries citing papers authored by Samuel J. Klempner

Since Specialization

Citations

This map shows the geographic impact of Samuel J. Klempner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel J. Klempner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel J. Klempner more than expected).

Fields of papers citing papers by Samuel J. Klempner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel J. Klempner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel J. Klempner. The network helps show where Samuel J. Klempner may publish in the future.

Co-authorship network of co-authors of Samuel J. Klempner

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel J. Klempner. A scholar is included among the top collaborators of Samuel J. Klempner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel J. Klempner. Samuel J. Klempner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study 2025 ·PubMed ·Samuel J. Klempner, Roberto Pazo-Cid, Sara Lonardi, (unknown), (unknown), Peter C. Enzinger, Andrew H. Ko, Gina M. Vaccaro, (unknown), Anwaar Saeed, K.-W. Lee, Kohei Shitara, David H. Ilson, Jaffer A. Ajani, (unknown), Stéphanie Braun, Michael S. Broder, (unknown)	4
2	DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B 2025 ·Nature Communications ·Keun Wook Lee, Devalingam Mahalingam, Byoung Yong Shim, In-Ho Kim, Do‐Youn Oh, Hope E. Uronis, Sun Jin Sym, Mohamad Bassam Sonbol, Khaldoun Almhanna, Mohamedtaki Abdulaziz Tejani, (unknown), Michael H. Kagey, (unknown), (unknown), Cynthia A. Sirard, (unknown), Jaffer A. Ajani, Samuel J. Klempner	0
3	PD-L1 immunohistochemistry in gastric cancer: Comparison of combined positive score and tumor area positivity across 28-8, 22C3, and SP263 assays. 2024 ·Journal of Clinical Oncology ·Samuel J. Klempner, (unknown), (unknown), Matteo Fassan, Hisato Kawakami, Hideaki Shimada, Laura H. Tang, Daniel‐Christoph Wagner, Yasushi Yatabe, Alexander Savchenko, (unknown), Dorhyun Johng, Lauren Fairchild, Jing Chen, (unknown), Markus Moehler	1
4	Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer 2024 ·Cancer Discovery ·Minae An, Arnav Mehta, Byung‐Hoon Min, You Jeong Heo, Samuel J. Wright, (unknown), Lynn Bi, Hyuk Lee, Tae Jun Kim, (unknown), Jeonghyeon Moon, Ryan J. Park, Matthew R. Strickland, Woong‐Yang Park, Won Ki Kang, Kyoung‐Mee Kim, Seung Tae Kim, Samuel J. Klempner, Jeeyun Lee	26
5	Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response 2024 ·JCO Precision Oncology ·Eric Lander, Vasily N. Aushev, Brandon M. Huffman, Diana L. Hanna, (unknown), (unknown), (unknown), Adham Jurdi, Minetta C. Liu, Cathy Eng, Samuel J. Klempner, Michael K. Gibson	1
6	Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer 2023 ·Science Advances ·Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M. Blum, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ho Yeong Lim, Samuel J. Klempner, Jeeyun Lee	36
7	Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers 2022 ·JCO Precision Oncology ·Brandon M. Huffman, Vasily N. Aushev, (unknown), Joseph Chao, Farshid Dayyani, Diana L. Hanna, Gregory P. Botta, Daniel V.T. Catenacci, Steven B. Maron, (unknown), Shruti Sharma, Giby V. George, Meenakshi Malhotra, Adham Jurdi, Solomon Moshkevich, Alexey Aleshin, Pashtoon Murtaza Kasi, Samuel J. Klempner	36
8	Real-world Validation of TMB and Microsatellite Instability as Predictive Biomarkers of Immune Checkpoint Inhibitor Effectiveness in Advanced Gastroesophageal Cancer 2022 ·Cancer Research Communications ·Ryon P. Graf, Virginia Fisher, James Creeden, Alexa B. Schrock, Jeffrey S. Ross, Halla Nimeiri, Geoffrey R. Oxnard, Samuel J. Klempner	7
9	Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation breakdown → 2021 ·Cancer Discovery ·Noritaka Tanaka, W. Marston Linehan, Chendi Li, Meagan B. Ryan, Junbing Zhang, Lesli A. Kiedrowski, Alexa Michel, Mohammed U. Syed, (unknown), Mustafa Sakhi, Islam Baiev, Dejan Juric, Justin F. Gainor, Samuel J. Klempner, Jochen K. Lennerz, Giulia Siravegna, Liron Bar‐Peled, Aaron N. Hata, Rebecca S. Heist, Ryan B. Corcoran	302
10	Retrospective Case Series Analysis ofRAFFamily Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies 2021 ·JCO Precision Oncology ·Andrew Hendifar, Edik M. Blais, Brian M. Wolpin, Vivek Subbiah, Eric A. Collisson, (unknown), Timothy Lewis Cannon, Kenna Shaw, Emanuel F. Petricoin, Samuel J. Klempner, Emily E. Lyons, Andrea Wang‐Gillam, Michael J. Pishvaian, Eileen M. O’Reilly	22
11	A Phase 2 Trial Combining Pembrolizumab and Palliative Radiation Therapy in Gastroesophageal Cancer to Augment Abscopal Immune Responses 2021 ·Advances in Radiation Oncology ·Joseph Chao, Ting-Fang He, Massimo D’Apuzzo, Yi‐Jen Chen, Paul Frankel, (unknown), Helen Chen, Shawn T. Solomon, Samuel J. Klempner, Marwan Fakih, Peter P. Lee	7
12	Endoscopic History and Provider Characteristics Influence Gastric Cancer Survival in Asian Americans 2020 ·Cancer Prevention Research ·Christie Y. Jeon, Yu‐Chen Lin, Samuel J. Klempner, Bechien U. Wu, Sungjin Kim, Kevin Waters, Robert W. Haile	4
13	Lineage-Specific Epigenomic and Genomic Activation of Oncogene HNF4A Promotes Gastrointestinal Adenocarcinomas 2020 ·Cancer Research ·Jian Pan, Tiago C. Silva, Nicole Gull, Qian Yang, Jasmine Plummer, Stephanie Chen, Kenji Daigo, Takao Hamakubo, Sigal Gery, Ling‐Wen Ding, Yan‐Yi Jiang, Shaoyan Hu, Li‐Yan Xu, En‐Min Li, Yanbing Ding, Samuel J. Klempner, Simon A. Gayther, Benjamin P. Berman, H. Phillip Koeffler, De‐Chen Lin	38
14	Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence 2019 ·The Oncologist ·Samuel J. Klempner, David Fabrizio, Shalmali Bane, Marcia Reinhart, Tim Peoples, Siraj M. Ali, Ethan S. Sokol, Garrett M. Frampton, Alexa B. Schrock, Rachel Anhorn, Prasanth Reddy	243
15	Progress and challenges in HER2-positive gastroesophageal adenocarcinoma 2019 ·Journal of Hematology & Oncology ·Dan Zhao, Samuel J. Klempner, Joseph Chao	43
16	Hybrid Capture–Based Genomic Profiling of Circulating Tumor DNA from Patients with Advanced Cancers of the Gastrointestinal Tract or Anus 2018 ·Clinical Cancer Research ·Alexa B. Schrock, Dean C. Pavlick, Samuel J. Klempner, Jon Chung, (unknown), Allison W. Welsh, Lauren Young, B Leyland-Jones, Rodolfo Bordoni, Richard D. Carvajal, Joseph Chao, Razelle Kurzrock, Jason K. Sicklick, Jeffrey S. Ross, Philip J. Stephens, Craig Devoe, Fadi Braiteh, Siraj M. Ali, Vincent A. Miller	54
17	Tumor Mutational Burden Guides Therapy in a Treatment Refractory POLE-Mutant Uterine Carcinosarcoma 2018 ·The Oncologist ·Munveer S. Bhangoo, Peter D. Boasberg, (unknown), Julia A. Elvin, Siraj M. Ali, (unknown), Samuel J. Klempner	45
18	Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer 2016 ·Dove Medical Press (Taylor and Francis Group) ·Phuong Tran, Samuel J. Klempner	5
19	Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences 2015 ·The Oncologist ·Kai Wang, Adrienne Johnson, Siraj M. Ali, Samuel J. Klempner, Tanios Bekaii‐Saab, Jeffrey Vacirca, Depinder Khaira, Roman Yelensky, Juliann Chmielecki, Julia A. Elvin, Doron Lipson, Vincent A. Miller, Philip J. Stephens, Jeffrey S. Ross	75
20	Safety of Cupping During Bevacizumab Therapy 2013 ·The Journal of Alternative and Complementary Medicine ·Samuel J. Klempner, Daniel B. Costa, Peggy A. Wu, (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact